235 related articles for article (PubMed ID: 33665914)
1. The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes.
Scaramuzza L; De Rocco G; Desiato G; Cobolli Gigli C; Chiacchiaretta M; Mirabella F; Pozzi D; De Simone M; Conforti P; Pagani M; Benfenati F; Cesca F; Bedogni F; Landsberger N
EMBO Mol Med; 2021 Apr; 13(4):e12433. PubMed ID: 33665914
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Supplementation Rescues Aberrant NF-κB Pathway Activation and Partially Ameliorates Rett Syndrome Phenotypes in
Ribeiro MC; Moore SM; Kishi N; Macklis JD; MacDonald JL
eNeuro; 2020; 7(3):. PubMed ID: 32393583
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
Ribeiro MC; MacDonald JL
Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
[TBL] [Abstract][Full Text] [Related]
4. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
[TBL] [Abstract][Full Text] [Related]
5. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
7. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.
Ogier M; Wang H; Hong E; Wang Q; Greenberg ME; Katz DM
J Neurosci; 2007 Oct; 27(40):10912-7. PubMed ID: 17913925
[TBL] [Abstract][Full Text] [Related]
9. Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice.
Matagne V; Wondolowski J; Frerking M; Shahidullah M; Delamere NA; Sandau US; Budden S; Ojeda SR
Brain Res; 2018 Oct; 1697():45-52. PubMed ID: 29902467
[TBL] [Abstract][Full Text] [Related]
10. Wide spectrum of neuronal and network phenotypes in human stem cell-derived excitatory neurons with Rett syndrome-associated MECP2 mutations.
Mok RSF; Zhang W; Sheikh TI; Pradeepan K; Fernandes IR; DeJong LC; Benigno G; Hildebrandt MR; Mufteev M; Rodrigues DC; Wei W; Piekna A; Liu J; Muotri AR; Vincent JB; Muller L; Martinez-Trujillo J; Salter MW; Ellis J
Transl Psychiatry; 2022 Oct; 12(1):450. PubMed ID: 36253345
[TBL] [Abstract][Full Text] [Related]
11. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes.
Flores Gutiérrez J; Natali G; Giorgi J; De Leonibus E; Tongiorgi E
Exp Neurol; 2022 Jul; 353():114056. PubMed ID: 35358499
[TBL] [Abstract][Full Text] [Related]
14. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
15. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.
Luikenhuis S; Giacometti E; Beard CF; Jaenisch R
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6033-8. PubMed ID: 15069197
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
Villani C; Sacchetti G; Carli M; Invernizzi RW
Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084
[TBL] [Abstract][Full Text] [Related]
17. Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation.
Wang IT; Reyes AR; Zhou Z
Neurobiol Dis; 2013 Oct; 58():3-12. PubMed ID: 23659895
[TBL] [Abstract][Full Text] [Related]
18. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
19. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
[TBL] [Abstract][Full Text] [Related]
20. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
